INNATE PHARMA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.245 EUR | +2.98% |
|
+6.40% | -14.31% |
Quotes 5-day view
Real-time Euronext Paris| 2024-04-23 | 2024-04-24 | 2024-04-25 | 2024-04-26 | |
|---|---|---|---|---|
| Last | 2.26 € | 2.235 € | 2.18 € | 2.245 € |
| Volume | 79 753 | 60 896 | 19 133 | 61 472 |
| Change | +4.39% | -1.11% | -2.46% | +2.98% |
| Opening | 2.19 | 2.25 | 2.24 | 2.23 |
| High | 2.27 | 2.26 | 2.25 | 2.26 |
| Low | 2.16 | 2.20 | 2.18 | 2.20 |
Performance
| 1 day | +2.98% | ||
| 1 week | +6.40% | ||
| Current month | +2.75% | ||
| 1 month | +2.51% | ||
| 3 months | -10.74% | ||
| 6 months | -3.02% | ||
| Current year | -14.31% | ||
| 1 year | -12.98% | ||
| 3 years | -34.93% | ||
| 5 years | -61.09% | ||
| 10 years | -65.93% |
Volumes
marketsDaily volume
61 472
Estimated daily volume
61 472
Avg. Volume 20 sessions
63 934
Daily volume ratio
0.96
Avg. Volume 20 sessions
143 531.83
Avg. Volume 20 sessions USD
153 467.10
Record volume 1
14 161 860
Record volume 2
10 742 570
Record volume 3
9 928 481
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
181 211 492
Capitalization (USD)
193 754 951
Net sales (EUR)
61 641 000
Net sales (USD)
65 907 790
Number of employees
179
Sales / Employee (EUR)
344 363
Sales / Employee (USD)
368 200
Free-Float
74.91 %
Free-Float capitalization (EUR)
135 780 902
Free-Float capitalization (USD)
145 179 656
Average Daily Capital Traded
0.08%
Highs and lows
1 week
2.11
2.27
1 month
2.112.39
Current year
2.112.80
1 year
2.113.35
3 years
1.998.30
5 years
1.998.30
10 years
1.9917.85
Indicators
Moving average 5 days
2.22
Moving average 20 days
2.24
Moving average 50 days
2.25
Moving average 100 days
2.35
Price spread / (MMA5)
-1.25%
Price spread / (MMA20)
-0.43%
Price spread / (MMA50)
+0.17%
Price spread / (MMA100)
+4.46%
STIM
RSI 9 days
44.52
RSI 14 days
45.44
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +2.98% | +6.40% | -14.31% | -12.98% | 194M | ||
| +0.38% | +2.98% | +1.51% | +27.89% | 42.75B | ||
| +2.72% | +4.97% | +49.22% | -3.97% | 41.61B | ||
| +1.69% | +6.47% | +8.57% | -16.99% | 41.34B | ||
| -0.45% | +2.14% | -12.36% | +8.21% | 26.59B | ||
| +2.74% | +6.97% | +8.92% | +61.66% | 25.49B | ||
| -0.28% | -0.76% | -25.13% | -26.90% | 18.12B | ||
| +1.58% | +6.43% | +29.17% | +100.43% | 12.24B | ||
| +0.54% | +0.99% | -3.12% | +24.67% | 11.76B | ||
| -0.89% | -1.71% | +6.35% | +2.70% | 11B | ||
| +2.23% | +3.12% | -16.98% | -17.55% | 10.07B | ||
| +1.39% | +4.12% | -6.98% | -8.70% | 9.22B | ||
| +2.53% | +3.12% | +24.77% | -14.18% | 6.65B | ||
| +8.85% | +16.24% | +4.97% | -37.00% | 6.44B | ||
| +1.78% | +2.98% | +25.38% | +56.89% | 6.13B | ||
| -.--% | -.--% | - | - | 6.07B | ||
| Average | +1.74% | +3.81% | +5.33% | +9.61% | ||
| Weighted average by Cap. | +1.41% | +3.69% | +8.96% | +10.88% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
01af59c3f8299f.LSacvQL_8jNedqDKAx0jiL-gNE9G1wLUM136NM36MmI.YWTb52WKg0IKD_CVYWpL0dyXfhoT5m-BfSiyZY-lc1IbSPjSMrKAXDwb0w
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 11:35:28 | 2.245 | 17 | 61,472 |
| 11:35:28 | 2.245 | 797 | 61,455 |
| 11:35:28 | 2.245 | 571 | 60,658 |
| 11:35:28 | 2.245 | 137 | 60,087 |
| 11:35:28 | 2.245 | 21 | 59,950 |
| 11:35:28 | 2.245 | 240 | 59,929 |
| 11:35:28 | 2.245 | 92 | 59,689 |
| 11:35:28 | 2.245 | 54 | 59,597 |
| 11:25:22 | 2.22 | 2,460 | 59,543 |
| 11:22:30 | 2.22 | 2,000 | 57,083 |
Monthly variations
Annual change
| 2024 | -14.31% | ||
| 2023 | -20.36% | ||
| 2022 | -26.03% | ||
| 2021 | +28.48% | ||
| 2020 | -41.91% | ||
| 2019 | -19.84% | ||
| 2018 | +56.53% | ||
| 2017 | -67.49% | ||
| 2016 | +7.90% | ||
| 2015 | +71.39% | ||
| 2014 | +59.27% | ||
| 2013 | +128.57% | ||
| 2012 | +58.39% | ||
| 2011 | +17.09% | ||
| 2010 | -51.45% | ||
| 2009 | +74.64% | ||
| 2008 | -62.19% | ||
| 2007 | -41.60% | ||
| 2006 | +29.40% |
- Stock Market
- Equities
- IPH Stock
- Quotes Innate Pharma
